Which formula?
| Drug | Note |
|---|---|
| Arsenic trioxide | ECG and electrolyte monitoring before and during treatment |
| Ribociclib | ECG at baseline, day 14 of cycle 1 and start of cycle 2 |
| Nilotinib, vandetanib | ECG monitoring; avoid other QT-prolonging drugs |
| High-dose IV ondansetron, methadone | Common supportive drugs with QT risk |
Fridericia QTc above 500 ms or a rise of more than 60 ms from baseline: stop the responsible drug, keep potassium and magnesium in the high-normal range and stop other QT-prolonging drugs [3]. Resume according to the drug label once QTc has improved.
References
3 referencesShow all references, 1 with a study cardClose the reference list
Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.
- 1Which QT Correction Formulae to Use for QT Monitoring?
- 2Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
- 32022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
This page is based on reputable scientific sources and was last updated on 27 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.
Printed from the website; the full and up-to-date version: https://drdabiri.com/en/tools/qtc-calculator/